Table 1.
ER | PR | HER2 | TNBC | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cohort | N | (+) | (–) | na | (+) | (–) | na | (+) | (–) | na | yes | no | na |
Gold standard | 871 | 751 | 113 | 7 | 678 | 187 | 6 | 116 | 453 | 302 | 44 | 682 | 145 |
Training | 436 | 379 | 54 | 3 | 345 | 90 | 1 | 64 | 216 | 156 | 20 | 346 | 70 |
Validation | 435 | 372 | 59 | 4 | 333 | 97 | 5 | 52 | 237 | 146 | 24 | 336 | 75 |
ER = estrogen receptor, PR = progesterone receptor, HER2 = human epidermal growth factor receptor, TN = triple negative, (+) = status positive, (–) = status negative, na = not available.